Skip to main content
. 2025 Feb 3;64(3):373–385. doi: 10.1007/s40262-025-01473-9

Fig. 2.

Fig. 2

Schematic diagram of the PBPK modeling approach to identify SLA and FE for a drug within the SR. Cmax maximum blood/plasma concentration, FaSSIF fasted state simulated intestinal fluid solubility, FE food effect, PBPK physiologically based pharmacokinetic model, SLA solubility-limited absorption, SR sensitivity range